Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for MediciNova, Inc. (MNOV : NSDQ)
 
 • Company Description   
MEDICINOVA, INC. is a publicly-traded biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical need with a specific focus on the U.S. market. Through strategic alliances primarily with Japanesepharmaceutical companies, MediciNova holds rights to a diversified portfolio of clinical and preclinical product candidates, each of which MediciNova believes has a well-characterized and differentiated therapeutic profile, attractive commercial potential and patent assets having claims of commercially adequate scope. MediciNova's pipeline includes six clinical-stage compounds for the treatment of status asthmaticus, multiple sclerosis, asthma, interstitial cystitis, solid tumor cancers, Generalized Anxiety Disorder, preterm labor and urinary incontinence and twopreclinical-stage compounds for the treatment of thrombotic disorders. MediciNova will seek to monetize its other product candidates at key value inflection points.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $3.13 Daily Weekly Monthly
20 Day Moving Average: 1,303,355 shares
Shares Outstanding: 49.04 (millions)
Market Capitalization: $153.50 (millions)
Beta: 1.33
52 Week High: $10.81
52 Week Low: $2.97
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -10.57% -7.78%
12 Week -23.28% -24.05%
Year To Date -40.49% -51.01%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
4275 EXECUTIVE SQUARE SUITE 300
-
LA JOLLA,CA 92037
USA
ph: 858-373-1500
fax: 858-404-0048
info@medicinova.com None
 
 • General Corporate Information   
Officers
Yuichi Iwaki - President and Chief Executive Officer
Jeff Himawan - Chairman of the Board of Directors
Chief Financial Officer - Edward Stepanow
Carolyn Beaver - Director
Kazuko Matsuda - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 58468P206
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/21
Next Expected EPS Date: 02/17/22
Share - Related Items
Shares Outstanding: 49.04
Most Recent Split Date: (:1)
Beta: 1.33
Market Capitalization: $153.50 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.10 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.26 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/17/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.77
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 12.50%
vs. Previous Quarter: 22.22%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
09/30/21 - -13.01
06/30/21 - -13.67
03/31/21 - -14.69
ROA
09/30/21 - -12.37
06/30/21 - -13.03
03/31/21 - -13.96
Current Ratio
09/30/21 - 18.13
06/30/21 - 31.99
03/31/21 - 44.49
Quick Ratio
09/30/21 - 18.12
06/30/21 - 31.99
03/31/21 - 44.49
Operating Margin
09/30/21 - -
06/30/21 - -
03/31/21 - -
Net Margin
09/30/21 - -
06/30/21 - -
03/31/21 - -
Pre-Tax Margin
09/30/21 - -273.35
06/30/21 - -279.07
03/31/21 - -283.24
Book Value
09/30/21 - 1.76
06/30/21 - 1.83
03/31/21 - 1.89
Inventory Turnover
09/30/21 - -
06/30/21 - -
03/31/21 - -
Debt-to-Equity
09/30/21 - 0.00
06/30/21 - 0.00
03/31/21 - 0.00
Debt-to-Capital
09/30/21 - 0.00
06/30/21 - 0.00
03/31/21 - 0.00
 

Powered by Zacks Investment Research ©